Table 3.
Open in new tab

Univariate analyses for baseline variables of interest and 1-year ER.

PredictorUnivariate
OR (95% CI)P
Disease duration0.93 (0.85-1.02)0.113
Disease location (ileocolonic vs isolated ileal)N/AN/A
Arm0.58 (0.16-2.16)0.420
Concomitant immunomodulator use0.75 (0.19-2.91)0.678
Concomitant corticosteroid use0.52 (0.06-3.76)0.559
Age1.00 (0.95-1.05)0.955
Sex (Female vs Male)0.84 (0.23-3.13)0.795
Smoking (Current vs not/never smoker)0.93 (0.24-3.64)0.915
Race (Caucasian vs non)N/AN/A
Baseline albumin1.05 (0.90-1.23)0.516
Baseline CRP1.00 (0.97-1.03)0.738
Baseline ileal SES-CD0.68 (0.49-0.95)0.025
Baseline medium or large ileal ulcer0.35 (0.09-1.40)0.137
Baseline CDAI1.00 (0.99-1.01)0.997
BMI0.99 (0.85-1.15)0.881
Fistula0.87 (0.24-3.22)0.838
Low hemoglobin (<115 g/L)0.28 (0.03-2.29)0.236
Prior anti-TNF-α exposure0.15 (0.03-0.76)0.023
PredictorUnivariate
OR (95% CI)P
Disease duration0.93 (0.85-1.02)0.113
Disease location (ileocolonic vs isolated ileal)N/AN/A
Arm0.58 (0.16-2.16)0.420
Concomitant immunomodulator use0.75 (0.19-2.91)0.678
Concomitant corticosteroid use0.52 (0.06-3.76)0.559
Age1.00 (0.95-1.05)0.955
Sex (Female vs Male)0.84 (0.23-3.13)0.795
Smoking (Current vs not/never smoker)0.93 (0.24-3.64)0.915
Race (Caucasian vs non)N/AN/A
Baseline albumin1.05 (0.90-1.23)0.516
Baseline CRP1.00 (0.97-1.03)0.738
Baseline ileal SES-CD0.68 (0.49-0.95)0.025
Baseline medium or large ileal ulcer0.35 (0.09-1.40)0.137
Baseline CDAI1.00 (0.99-1.01)0.997
BMI0.99 (0.85-1.15)0.881
Fistula0.87 (0.24-3.22)0.838
Low hemoglobin (<115 g/L)0.28 (0.03-2.29)0.236
Prior anti-TNF-α exposure0.15 (0.03-0.76)0.023
Table 3.
Open in new tab

Univariate analyses for baseline variables of interest and 1-year ER.

PredictorUnivariate
OR (95% CI)P
Disease duration0.93 (0.85-1.02)0.113
Disease location (ileocolonic vs isolated ileal)N/AN/A
Arm0.58 (0.16-2.16)0.420
Concomitant immunomodulator use0.75 (0.19-2.91)0.678
Concomitant corticosteroid use0.52 (0.06-3.76)0.559
Age1.00 (0.95-1.05)0.955
Sex (Female vs Male)0.84 (0.23-3.13)0.795
Smoking (Current vs not/never smoker)0.93 (0.24-3.64)0.915
Race (Caucasian vs non)N/AN/A
Baseline albumin1.05 (0.90-1.23)0.516
Baseline CRP1.00 (0.97-1.03)0.738
Baseline ileal SES-CD0.68 (0.49-0.95)0.025
Baseline medium or large ileal ulcer0.35 (0.09-1.40)0.137
Baseline CDAI1.00 (0.99-1.01)0.997
BMI0.99 (0.85-1.15)0.881
Fistula0.87 (0.24-3.22)0.838
Low hemoglobin (<115 g/L)0.28 (0.03-2.29)0.236
Prior anti-TNF-α exposure0.15 (0.03-0.76)0.023
PredictorUnivariate
OR (95% CI)P
Disease duration0.93 (0.85-1.02)0.113
Disease location (ileocolonic vs isolated ileal)N/AN/A
Arm0.58 (0.16-2.16)0.420
Concomitant immunomodulator use0.75 (0.19-2.91)0.678
Concomitant corticosteroid use0.52 (0.06-3.76)0.559
Age1.00 (0.95-1.05)0.955
Sex (Female vs Male)0.84 (0.23-3.13)0.795
Smoking (Current vs not/never smoker)0.93 (0.24-3.64)0.915
Race (Caucasian vs non)N/AN/A
Baseline albumin1.05 (0.90-1.23)0.516
Baseline CRP1.00 (0.97-1.03)0.738
Baseline ileal SES-CD0.68 (0.49-0.95)0.025
Baseline medium or large ileal ulcer0.35 (0.09-1.40)0.137
Baseline CDAI1.00 (0.99-1.01)0.997
BMI0.99 (0.85-1.15)0.881
Fistula0.87 (0.24-3.22)0.838
Low hemoglobin (<115 g/L)0.28 (0.03-2.29)0.236
Prior anti-TNF-α exposure0.15 (0.03-0.76)0.023
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close